Attainment of glycaemic goals by step-up therapy with biphasic insulin aspart-70/30 in Japanese type 2 diabetic patients

被引:5
|
作者
Hosoi, Yasuhiro [2 ]
Ohtani, Ken-Ichi [2 ]
Shimizu, Hiroyuki [1 ]
Kashima, Kouji [3 ]
Sato, Noriyuki [4 ]
Akiyama, Hitoshi [5 ]
Mori, Masatomo [6 ]
机构
[1] Kiryu Univ, Fac Hlth Care, Midori Ku, Gunma 3792392, Japan
[2] Isesaki City Hosp, Dept Internal Med, Isesaki, Japan
[3] Kiryu Kosei Gen Hosp, Dept Internal Med, Kiryu, Gunma, Japan
[4] Sato Clin, Gunma, Japan
[5] Toho Hosp, Dept Internal Med, Midori, Japan
[6] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan
关键词
Biphasic insulin aspart-70/30; HbA1c; Type; 2; diabetes;
D O I
10.1507/endocrj.K10E-307
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have made step-up titration protocol with biphasic insulin aspart-70/30 (BIAsp 30), and tried to achieve glycemic goals in poorly controlled Japanese type 2 diabetic patients. We summarized all results obtained to analyze the effectiveness of our protocol. The target of glycaemic control was defined as HbA1c over 7.0%. In our insulin initiation protocol, all patients started a once-daily injection of BIAsp 30 before the breakfast in addition to their oral hypoglycaemic agents. The patients who could not achieve the target from 12 to 16 weeks after the start of insulin treatment proceeded to twice daily insulin injection before breakfast and dinner. Next, the patients who could not achieve the target from 12 to 16 weeks after the addition of another BIAsp injection proceeded to thrice daily insulin injection before each meal a day. The results of 39 patients were analyzed, and 10.3 % of all patients achieved the target after the start of once daily injection of BIAsp 30, 41.7 % achieved in twice daily injection of BIAsp, and 51.4% achieved in thrice daily injection of BIAsp. Daily insulin dose at the end of each treatment was 9.3+/-4.1 U in once daily, 17.4+/-6.3 U in twice daily, and 28.4+/-10.4 U in thrice daily. Total body weight increase by 2.0+/-2.6 kg. The initiation and titration protocol with BIAsp 30 improved glycaemic control, and increased the number of patients with the achievement of glycaemic goals.
引用
收藏
页码:131 / 135
页数:5
相关论文
共 50 条
  • [1] Step-up therapy with biphasic insulin aspart-70/30-Sapporo 1-2-3 study
    Yoshioka, N.
    Kurihara, Y.
    Manda, N.
    Komori, K.
    Kato, M.
    Kijima, H.
    Wada, N.
    Yanagisawa, K.
    Aoki, S.
    Ono, Y.
    Koike, T.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 85 (01) : 47 - 52
  • [2] Step-Up Treatment with Premixed Insulin Lispro-50/50 vs. Premixed Human Insulin Aspart-70/30: A Randomized Trial in Type 2 Diabetic Patients
    Ikeda, Shiori
    Monden, Tsuyoshi
    Matsumura, Mihoko
    Shimizu, Hiroaki
    Nakatani, Yuki
    Miyashita, Yasushi
    Domeki, Nozomi
    Yanagi, Kazunori
    Kasai, Kikuo
    [J]. DIABETES, 2010, 59 : A142 - A142
  • [3] A Randomized Trial of Step-up Treatment with Premixed Insulin Lispro-50/50 vs. Aspart-70/30 in Patients with Type 2 Diabetes Mellitus
    Domeki, Nozomi
    Matsumura, Mihoko
    Monden, Tsuyoshi
    Nakatani, Yuki
    Aso, Yoshimasa
    [J]. DIABETES THERAPY, 2014, 5 (02) : 403 - 413
  • [4] A Randomized Trial of Step-up Treatment with Premixed Insulin Lispro-50/50 vs. Aspart-70/30 in Patients with Type 2 Diabetes Mellitus
    Nozomi Domeki
    Mihoko Matsumura
    Tsuyoshi Monden
    Yuki Nakatani
    Yoshimasa Aso
    [J]. Diabetes Therapy, 2014, 5 : 403 - 413
  • [5] Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study)
    Garber, AJ
    Wahlen, J
    Wahl, T
    Bressler, P
    Braceras, R
    Allen, E
    Jain, R
    [J]. DIABETES OBESITY & METABOLISM, 2006, 8 (01): : 58 - 66
  • [6] GLYCAEMIC CONTROL AND INSULIN UTILIZATION IN UK PATIENTS WITH TYPE 2 DIABETES INITIATED ON EITHER BIPHASIC INSULIN ASPART 30 OR BIPHASIC HUMAN INSULIN 30
    Fakhoury, W.
    Richter, H.
    Christensen, T.
    Thomsen, T. L.
    Irwin, D.
    Anderson, P.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A55 - A55
  • [7] Biphasic Insulin Aspart 30 (BIAsp 30) is Safe and Improves Glycaemic Control in Insulin Naive Patients with Type 2 Diabetes
    Esteghamati, Alireza
    Nakhjavani, Manouchehr
    Aminorroaya, Ashraf
    Aboutorabi, Robabeh
    Niafar, Mitra
    Mohammadi, Mohammad
    Parvaresh, Ehsan
    [J]. JOURNAL OF DIABETES & METABOLISM, 2011, 2 (03)
  • [8] Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
    Valensi, Paul
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2009, 2 : 61 - 71
  • [9] Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin
    Kilo, C
    Mezitis, N
    Jain, R
    Mersey, J
    McGill, J
    Raskin, P
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2003, 17 (06) : 307 - 313
  • [10] Thrice-daily injections of biphasic insulin aspart 30 (NovoMix® 70/30) improves glycaemic control in patients with type 1 diabetes
    Chen, JW
    Lauritzen, T
    Bojesen, A
    Christiansen, J
    [J]. DIABETOLOGIA, 2005, 48 : A330 - A330